Toshiba develops gamma camera upgrades
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems,
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems, according to Steve Sickels, divisionmanager.
Toshiba displayed transmission-emission attenuation correctionas a work-in-progress at last year's Radiological Society of NorthAmerica meeting. The technique was shown on Toshiba's triple-headGCA-9300A camera, but Toshiba also has an active R&D programin Japan to bring the technology to the dual-head GCA-7200A, accordingto Sickels. The dual-head version, which is also a work-in-progress,will involve a combination of a stationary line source of radioactivityand collimation, he said. GCA-7200A is an opposable dual-headcamera.
Toshiba also has a program in the works to develop 511-keVcollimators for SPECT imaging with fluorodeoxyglucose (FDG), Sickelssaid.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
